SciELO - Scientific Electronic Library Online

 
vol.6 issue1"Tailored TAVI": the importance of the deployment mechanismTransjugular left atrial appendage closure author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


REC: Interventional Cardiology

On-line version ISSN 2604-7276Print version ISSN 2604-7306

REC Interv Cardiol ES vol.6 n.1 Madrid Jan./Mar. 2024  Epub Mar 18, 2024

https://dx.doi.org/10.24875/recic.m23000409 

Images in cardiology

Implantation of a pulmonary bioprosthetic valve in a single pulmonary artery

Luis Fernández-González1  *  , Roberto Blanco-Mata1  , Koldobika García-San Román1  , Juan Carlos Astorga-Burgo1  , Aída Acín-Labarta1  , Josune Arriola-Meabe1 

1Sección de Cardiología Intervencionista, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España

We present the case of a 19-year-old woman with DiGeorge syndrome associated with psychomotor retardation, tetralogy of Fallot, and right pulmonary artery agenesis, treated with right ventricular outflow tract (RVOT) transannular patch augmentation during childhood, with severe pulmonary regurgitation and progressive right ventricular enlargement. As a result, pulmonary valve replacement was indicated. Cardiac computed tomography (CT) revealed the presence of severe scoliosis, right sternal deviation, and an elongated RVOT with a minimum diameter of 26 mm at the annular level and 30 mm at the supravalvular level (figure 1A-D, arrows). Because of the clinical and biomechanical characteristics, the anatomy of the RVOT, and the presence of a single pulmonary artery, we performed transcatheter implantation of a self-expanding bioprosthetic Venus valve (Medtech, China). Other valves suitable for large-caliber RVOTs, such as the Myval (Meril, India) have not been granted CE marking for pulmonary implantation.

Figure 1. 

Prior to implantation, the RVOT was sized, and coronary compression was ruled out after occlusive inflation with a 35-mm PTS-X sizing balloon catheter (NuMED, United States). The measurements obtained were consistent with the CT scan results. Consequently, a 30-mm to 25-mm valve was selected (figure 2A,B). A 24-Fr GORE DrySeal introducer sheath and an extra stiff Lunderquist wire guide (Cook Medical, United States) were used to access the left pulmonary artery and progressively deploy the valve initially from the distal segment at the origin of the pulmonary artery and subsequently the proximal segment. Withdrawal of the introducer sheath revealed optimal apposition to the RVOT (figure 2C-F; videos 1 to 4 of the supplementary data). The patient was discharged from hospital 24 hours later, and the valve has remained fully functional ever since with no signs of residual valvular regurgitation.

Figure 2. 

The patient and her family gave their written informed consent for the publication of this article.

ETHICAL CONSIDERATIONS

The work has been approved by the ethics committee of our centre. Informed consent was obtained from the patient and family. Our work has not taken into account possible sex and gender variables in accordance with SAGER guidelines.

STATEMENT ON THE USE OF ARTIFICIAL INTELLIGENCE

No artificial intelligence was used.

FUNDINGNone declared.

SUPPLEMENTARY DATA

https://doi.org/10.24875/RECICE.M23000407

Supplementary data associated with this article can be found in the online version available at https://doi.org/10.24875/RECICE.M23000407.

Received: June 12, 2023; Accepted: July 14, 2023; pub: September 04, 2023

*Corresponding author. E-mail address: luisfg82@hotmail.com (L. Fernández González). ✗ @hemodinamicacr10

CONFLICTS OF INTEREST

None declared.

AUTHORS’ CONTRIBUTIONS

All the authors contributed equally to this work.

Creative Commons License Sociedad Española de Cardiología. Publicado por Permanyer Publications. Este es un artículo open access bajo la licencia CC BY-NC-ND 4.0